Literature DB >> 12688421

Aromatic trap analysis of free radicals production in experimental collagen-induced arthritis in the rat: protective effect of glycosaminoglycans treatment.

Giuseppe M Campo1, Angela Avenoso, Salvatore Campo, Alida Ferlazzo, Domenica Altavilla, Carmelo Micali, Alberto Calatroni.   

Abstract

Many findings demonstrated that Glycosaminoglycans (GAGs) and Proteoglycans (PGs) possess antioxidant activity. Collagen-induced arthritis (CIA) is an experimental animal model similar to human rheumatoid arthritis (RA) in which free radicals are involved. Sodium salicylate can be used as a chemical trap for hydroxyl radicals (OH*), the most damaging reactive oxygen species (ROS), yielding 2,5-dihydroxybenzoic acid), (2,5-DHBA) and 2,3-dihydroxybenzoic acid (2,3-DHBA). The measurement of these two acids in the plasma allows to indirectly assess the production of OH* radicals. The aim of the study was to investigate the effect of hyaluronic acid (HYA) (30 mg/kg i.p.) or chondroitin-4-sulphate (C4S) (30 mg/kg i.p.), on free radical production in Lewis rats subjected to CIA. After the immunization with bovine collagen type II in complete Freund's adjuvant, rats developed an erosive hind paw arthritis, that produced high plasma OH* levels assayed as 2,3-DHBA and 2,5-DHBA, primed lipid peroxidation, evaluated by analyzing conjugated dienes (CD) in the articular cartilage; decreased the concentration of endogenous vitamin E (VE) and catalase (CA) in the joint cartilage; enhanced macrophage inflammatory protein-2 (MIP-2) serum levels and increased elastase (ELA) evaluated as an index of activated leukocyte polymophonuclear (PMNs) accumulation in the articular joints. The administration of HYA and C4S starting at the onset of arthritis (day 11) for 20 days, limited inflammation and the clinical signs in the knee and paw, reduced OH* production, decreased CD levels, partially restored the endogenous antioxidants VE and CA, reduced MIP-2 serum levels and limited PMNs infiltration. The results indicate that the GAGs HYA and C4S significantly reduce free radical production in CIA and could be used as a tool to investigate the role of antioxidants in RA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12688421     DOI: 10.1080/1071576021000046640

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  6 in total

1.  Antioxidant capacity and oxidative damage determination in synovial fluid of chronically damaged equine metacarpophalangeal joint.

Authors:  Alejandro Villasante; Oscar F Araneda; Claus Behn; Marco Galleguillos; Hector Adarmes
Journal:  Vet Res Commun       Date:  2009-12-12       Impact factor: 2.459

2.  Sex-Specific Reduction in Inflammation of Osteoarthritic Human Chondrocytes and Nutraceutical-Dependent Extracellular Matrix Formation.

Authors:  Alia Mallah; Mahmoud Amr; Haneen Abusharkh; Bernard Van Wie; Arda Gozen; Juana Mendenhall; Edwin Tingstad; Vincent Idone; Nehal I Abu-Lail
Journal:  J Immunol Regen Med       Date:  2021-10-08

3.  Alleviation of cell damage in experimental ANP in rats by administration of chondroitin-sulfate reduces.

Authors:  Zhongye He; Renxuan Guo; Chengyao Xie; Nan Liu; Yang Li; Wen Song
Journal:  Front Med China       Date:  2007-02

Review 4.  Chondroitin sulphate: a focus on osteoarthritis.

Authors:  Mamta Bishnoi; Ankit Jain; Pooja Hurkat; Sanjay K Jain
Journal:  Glycoconj J       Date:  2016-05-19       Impact factor: 2.916

5.  Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells.

Authors:  Hong Zhao; Toshiki Tanaka; Vadim Mitlitski; Julie Heeter; Endre A Balazs; Zbigniew Darzynkiewicz
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

6.  Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis.

Authors:  Andreas Roth; Jürgen Mollenhauer; Andreas Wagner; Reneè Fuhrmann; Albrecht Straub; Rudolf A Venbrocks; Peter Petrow; Rolf Bräuer; Harald Schubert; Jörg Ozegowski; Gundela Peschel; Peter J Müller; Raimund W Kinne
Journal:  Arthritis Res Ther       Date:  2005-03-31       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.